<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1753425</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2026.1753425</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metformin-loaded J-AuPPS for infected diabetic wound treatment</article-title>
<alt-title alt-title-type="left-running-head">Yin et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2026.1753425">10.3389/fbioe.2026.1753425</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yin</surname>
<given-names>Fuli</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3292498"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yang</surname>
<given-names>Lingkai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1396979"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shan</surname>
<given-names>Haojie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/665189"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yuange</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1117818"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Yongfeng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yu</surname>
<given-names>Xiaowei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/601352"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Shanghai Sixth People&#x2019;s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</institution>, <city>Shanghai</city>, <country country="CN">China</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>School of Chemistry and Chemical Engineering Frontiers Science Center for Transformative Molecules, Shanghai Jiao Tong University</institution>, <city>Shanghai</city>, <country country="CN">China</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Xiaowei Yu, <email xlink:href="mailto:yuxw@sjtu.edu.cn">yuxw@sjtu.edu.cn</email>; Yongfeng Zhou, <email xlink:href="mailto:yfzhou@sjtu.edu.cn">yfzhou@sjtu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>&#x2020;</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-19">
<day>19</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>14</volume>
<elocation-id>1753425</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Yin, Yang, Shan, Li, Zhou and Yu.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Yin, Yang, Shan, Li, Zhou and Yu</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-19">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Infected diabetic wounds pose a significant clinical challenge owing to the complex wound microenvironment. Various multifunctional synergistic therapeutic nanomaterials have been successfully developed to treat diabetic infected wounds.</p>
</sec>
<sec>
<title>Objective</title>
<p>A Janus Au&#x2013;porphyrin polymersome heterostructure loaded with metformin (Met@J-AuPPS) is constructed and presented.</p>
</sec>
<sec>
<title>Methods</title>
<p>Porphyrin polymersome vesicles loaded with metformin (Met@PPS) was synthesized by supramolecular polymerization enhanced self-assembly. Metformin-loaded Janus gold-porphyrin polymersome (Met@J-AuPPS) was synthesized by photocatalytic synthesis method. Transmission electron microscope (TEM), scanning electron microscope (SEM), UV-vis absorption spectrum and ELISA experiment were used to detect the morphology, structure, photothermal properties and drug release properties of Met@J-AuPPS. The effects of Met@J-AuPPS on the proliferation and activity of HUVECs were detected by CCK-8 test, scratch test, Transwell test and tube formation test. The antibacterial and antibiofilm abilities of Met@J-AuPPS were detected by blood plate test, crystal violet staining, SEM of biofilm and bacterial live/dead staining. Imaging and histological staining were used to detect the efficacy of Met@J-AuPPS in treating diabetic wound infections <italic>in vivo</italic>.</p>
</sec>
<sec>
<title>Results</title>
<p>Excellent photothermal antibacterial performance against gram-positive methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA), gram-negative extended-spectrum &#x3b2;-lactamases <italic>Escherichia coli</italic> (ESBL <italic>E. coli</italic>), and MRSA/ESBL <italic>E. coli</italic> biofilm is demonstrated by a strong non-centrosymmetric near-field enhancement (NFE) effect between Met@PPS and Au nanoparticles. Furthermore, the release of metformin under near-infrared (NIR) light promotes angiogenesis and tissue repair. The results therefore show that Met@J-AuPPS exhibits excellent antibacterial/biofilm and pro-angiogenic performance, with significantly enhanced therapeutic effects in infected wounds of diabetic rat models.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>This study presents an innovative therapeutic strategy for diabetic wound infections and demonstrates that Met@J-AuPPS has potential as a multifunctional and upgradeable nanoplatform for further biomedical applications.</p>
</sec>
</abstract>
<kwd-group>
<kwd>angiogenesis</kwd>
<kwd>antibacterial</kwd>
<kwd>diabetic wound infection</kwd>
<kwd>Janus particles</kwd>
<kwd>photothermal therapy</kwd>
<kwd>synergistic therapy</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. Financial support from National Natural Science Foundation of China (82372387,22231007) and Medical-Engineering Cross Foundation of Shanghai Jiao Tong University (YG2024ZD19).</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="12"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Biomaterials</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Diabetes, the most prevalent chronic metabolic disease worldwide, places a significant burden on the healthcare systems and society (<xref ref-type="bibr" rid="B35">Tomic et al., 2022</xref>; <xref ref-type="bibr" rid="B39">Yazdanpanah et al., 2015</xref>). Diabetic foot ulcers (DFU), which affect 18.6 million people globally each year, are linked to decreased quality of life, increased healthcare utilization, and impaired physical activity (<xref ref-type="bibr" rid="B2">Armstrong et al., 2023</xref>; <xref ref-type="bibr" rid="B13">Hicks et al., 2016</xref>). Diabetic wounds create a fertile environment for bacterial colonization. The two main clinical strategies for treating DFU are surgical debridement and antibiotic therapy (<xref ref-type="bibr" rid="B7">Chen et al., 2023a</xref>; <xref ref-type="bibr" rid="B33">Senneville et al., 2023</xref>). However, the administration of antibiotics at high doses frequently results in severe side effects, including life-threatening complications from drug-resistant bacterial infections (<xref ref-type="bibr" rid="B14">Hussain et al., 2018</xref>; <xref ref-type="bibr" rid="B3">Aumiller and Dollahite, 2015</xref>). A study by Alvaro-Afonso et al. compared the clinical outcomes of DFU caused by gram-positive methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) and gram-positive methicillin-sensitive <italic>Staphylococcus aureus</italic> (MSSA). Their results showed that patients with MRSA had longer mean healing time compared to infections caused by MSSA (<xref ref-type="bibr" rid="B1">&#xc1;lvaro-Afonso et al., 2025</xref>). And patients with MRSA used more antibiotics during the 1-year follow-up in another study (<xref ref-type="bibr" rid="B34">Suludere et al., 2024</xref>). Furthermore, the process of creating new antibiotics is getting harder and harder (<xref ref-type="bibr" rid="B11">Farha et al., 2018</xref>). In addition, diabetic wounds heal more slowly than normal wounds owing to chronic inflammation, decreased angiogenesis, and granulation tissue production, which can potentially result in amputation. (<xref ref-type="bibr" rid="B38">Wang et al., 2021</xref>; <xref ref-type="bibr" rid="B15">Koh and DiPietro, 2011</xref>).</p>
<p>Therefore, a variety of multifunctional synergistic therapeutic nanomaterials, including silver nanoparticles (<xref ref-type="bibr" rid="B9">Choudhury et al., 2020</xref>; <xref ref-type="bibr" rid="B29">P&#xe9;rez-Rafael et al., 2021</xref>), gold nanoparticles (<xref ref-type="bibr" rid="B37">Vijayakumar et al., 2019</xref>; <xref ref-type="bibr" rid="B4">Boomi et al., 2020</xref>), metal&#x2013;organic frameworks (<xref ref-type="bibr" rid="B22">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="B44">Zhang et al., 2022</xref>) and peptides (<xref ref-type="bibr" rid="B16">Krizsan et al., 2014</xref>), have been successfully produced to treat diabetic infected wounds in addition to standard therapy. Multifunctional nanoplatforms are appealing approaches for the treatment of infected diabetic wounds due to their strong antibacterial qualities and great efficacy in encouraging wound healing, as evidenced by the materials&#x2019; exceptional performance. (<xref ref-type="bibr" rid="B27">P et al., 2025</xref>).</p>
<p>Janus nanoparticles (JNPs) have demonstrated great potential in the biomedical field among these many nanomaterials because they combine the mechanical, photoelectronic, and magnetic properties of inorganic materials with the benefits of polymers, including biocompatibility, environmental responsiveness, and ease of processing (<xref ref-type="bibr" rid="B30">Qiu et al., 2021</xref>; <xref ref-type="bibr" rid="B42">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="B20">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B19">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="B5">Cao et al., 2021</xref>). In our earlier study, we used a one-step photocatalytic synthesis approach to successfully create a Janus Au-porphyrin polymersome (J-AuPPS) heterostructure. This technique produced a high near-field enhancement (NFE) effect, which improves the intensity of the interfacial electric/thermal field and the absorption of near-infrared (NIR) light. Both <italic>in vitro</italic> and <italic>in vivo</italic>, J-AuPPS exhibits encouraging photothermal antibacterial and anti-biofilm action. (<xref ref-type="bibr" rid="B8">Chen et al., 2023b</xref>). The polymersome in the J-AuPPS can be loaded with medications, targeting compounds, and diagnostic chemicals, offering an effective and expandable nanoplatform for additional medical applications.</p>
<p>Metformin is the first-line anti-diabetic drug (<xref ref-type="bibr" rid="B17">LaMoia and Shulman, 2021</xref>). Early studies suggest that the liver is the major organ involved in the reduction of blood glucose levels by metformin (<xref ref-type="bibr" rid="B12">Foretz et al., 2023</xref>). However, increasing evidence points to other important roles (<xref ref-type="bibr" rid="B12">Foretz et al., 2023</xref>; <xref ref-type="bibr" rid="B10">Dutta et al., 2023</xref>), including cardiovascular protection (<xref ref-type="bibr" rid="B24">Luo et al., 2019</xref>), anti-cancer effects (<xref ref-type="bibr" rid="B41">Zakikhani et al., 2006</xref>), neuroprotective effects (<xref ref-type="bibr" rid="B28">Palleria et al., 2016</xref>), anti-aging effects (<xref ref-type="bibr" rid="B6">Chen et al., 2022</xref>), and anti-inflammatory effects (<xref ref-type="bibr" rid="B23">Liu et al., 2023</xref>). Through mitochondrial autophagy, metformin also lessens the damage that hyperglycemia causes to endothelial cells and prevents microvascular damage in high-glucose conditions (<xref ref-type="bibr" rid="B26">Niu et al., 2019</xref>). Using metformin-release hydrogel dressings, Liang et al. helped patients with type II diabetes heal foot wounds by lowering inflammation and increasing angiogenesis through wound closure, re-epithelialization, blood vessel and follicle regeneration, and collagen metabolism (<xref ref-type="bibr" rid="B18">Liang et al., 2022</xref>). <italic>In vitro</italic> and <italic>in vivo</italic>, Ruan et al. discovered that metformin stimulated angiogenesis by blocking YAP1/TAZ in endothelial cells, which promoted the expression of HIF-1&#x3b1;. (<xref ref-type="bibr" rid="B32">Ruan et al., 2023</xref>). The drug-bioactive material combination synergistically promotes wound healing; however, it remains unclear whether the combinatorial effect of metformin and J-AuPPS in infected chronic diabetic wound healing is additive or synergistic.</p>
<p>Here, we report the construction of a Janus Au&#x2013;porphyrin polymersome heterostructure loaded with metformin (Met@J-AuPPS) (<xref ref-type="scheme" rid="sch1">Scheme 1</xref>). First, aqueous self-assembly of porphyrin hyperbranched polymers of 5,10,15,20-tetrakis (4-hydroxyphenyl) porphyrin Zinc (ZnTHPG) produced a porphyrin polymersome loaded with metformin (Met@PPS). Second, <italic>in situ</italic> photoreduction of Au ions followed by an Ostwald ripening process produced a unique Janus particle of Met@J-AuPPS, which is composed of a Met@PPS and an Au NP connected by the interconnecting interface. At the interface of Met@PPS and Au nanoparticles, a potent near-field enhancement (NFE) effect was produced, leading to both a larger electric/thermal field and better near-infrared absorption (<xref ref-type="bibr" rid="B43">Zhang et al., 2019</xref>). Met@J-AuPPS appears to display excellent photothermal antibacterial performance against gram-positive methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA), gram-negative extended-spectrum &#x3b2;-lactamases <italic>Escherichia coli</italic> (ESBL <italic>E. coli</italic>), and MRSA/ESBL <italic>E. coli</italic> biofilm <italic>in vitro</italic>. Met@J-AuPPS demonstrated clear angiogenic ability <italic>in vitro</italic> and markedly enhanced the migration and tube formation of human umbilical vein endothelial cells (HUVECs) upon near-infrared (NIR)-triggered drug release. Most importantly, Met@J-AuPPS Met@J-AuPPS demonstrated excellent promise in phototherapy for infected diabetic wounds. These results demonstrate that Met@J-AuPPS is bio-safe <italic>in vivo</italic> and is effective in eliminating MRSA biofilm on the wound under NIR irradiation. Synergistically, metformin can reduce inflammation, promote collagen secretion, and induce wound neovascularization.</p>
<fig id="sch1" position="float">
<label>SCHEME 1</label>
<caption>
<p>Schematic illustration of the preparation, electromagnetic NFE mechanism therapeutic effect of Met@J&#x2010;AuPPS.</p>
</caption>
<graphic xlink:href="FBIOE_fbioe-2026-1753425_wc_sch1.tif">
<alt-text content-type="machine-generated">Scientific diagram illustrating the assembly of Met@J-AuPPS nanoparticles for photothermal therapy and metformin release in diabetic infected wounds, showing angiogenesis, MRSA killing, wound healing in diabetic rats, and electric field intensity during laser activation.</alt-text>
</graphic>
</fig>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Preparation of Met@J-AuPPS</title>
<p>The Met@PPS was synthesized following previous methods (<xref ref-type="bibr" rid="B21">Liu et al., 2020</xref>). Hydrophilic-hydrophobic interactions and supramolecular polymerization between porphyrin molecules were started by gradually adding water to the polymer&#x2019;s solvent solution. Typically, 10&#xa0;mg of polymer and 0.1/0.2/0.5&#xa0;mg metformin were dissolved in 5&#xa0;mL of DMF, and, after sonication for 10&#xa0;min, filtered through a nylon filter with a pore size of 22&#xa0;&#xb5;g. Then, 10&#xa0;mL of deionized water was slowly added, dropwise, to the above solution. This was followed by transfer to a dialysis bag with a molecular weight cut-off of 3,500&#xa0;Da and dialysis in water for 48&#xa0;h to remove DMF to obtain an aqueous solution of polymer vesicles. The volume of the assembly solution was used to calculate the vesicle concentration. Met@PPS aqueous solution (40&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>) was dispersed by ultrasonication for 10&#xa0;min; then, HAuCl<sub>4</sub> (10&#xa0;mM, equivalent to 15&#xa0;wt% Au) was added to the solution and stirred for 5&#xa0;min in the dark, followed by reaction at 25&#xa0;&#xb0;C under visible light (&#x3bb; &#x3e; 420&#xa0;nm, 300&#xa0;W mercury lamp) for 1&#xa0;h. The color of the solution deepened as the gold ions were reduced. After photoreaction, excess ions were removed by centrifugation and washing with deionized water for three times to obtain Janus-shaped Met@J-AuPPS.</p>
</sec>
<sec id="s2-2">
<title>Scanning Electron Microscopy (SEM)</title>
<p>The sample preparation process was carried out as follows: the assembly solution (0.1&#xa0;mg&#xa0;mL<sup>-1</sup>) was dropped on a clean silicon wafer, and, after air-drying, gold ions were sprayed on the surface of the sample. Then, SEM images were acquired with a Nova NanoSEM 450 field emission scanning electron microscope (FEI Corporation, United States).</p>
</sec>
<sec id="s2-3">
<title>Transmission Electron Microscopy (TEM)</title>
<p>The sample preparation process was as follows: the assembly solution (0.1&#xa0;mg&#xa0;mL<sup>-1</sup>) was dropped on a 200-mesh carbon film, and then air-dried for TEM photography on a Tecnai G2 biotype transmission electron microscope (Thermofisher, United States).</p>
</sec>
<sec id="s2-4">
<title>UV-Vis absorption spectrum</title>
<p>The UV-Vis absorption spectra of polymers, assemblies, and composite structures were tested on a Lambda 35 UV-Vis absorption spectrometer (PerkinElmer, United States). The sample solution was dispersed in a 1 &#xd7; 1&#xa0;cm quartz cell and the test temperature was 298&#xa0;K.</p>
</sec>
<sec id="s2-5">
<title>
<sup>1</sup>H Nuclear Magnetic Resonance (<sup>1</sup>H NMR)</title>
<p>Five to 10&#xa0;mg of sample was dissolved in 0.6&#xa0;mL of deuterated reagent (DMSO-<italic>d</italic>
<sub>
<italic>6</italic>
</sub>), and then tested with a AVANCE III HD 400 nuclear magnetic resonance spectrometer (Bruker, United States). DMSO or TMS was used as the internal standard, and the test temperature was 298&#xa0;K.</p>
</sec>
<sec id="s2-6">
<title>Gel Permeation Chromatography (GPC)</title>
<p>Gel permeation chromatography of ZnTHPG was performed on a HLC-8320GPC gel permeation chromatograph (Tosoh Corporation, Japan). A solution with a polymer concentration of 10&#xa0;mg&#xa0;mL<sup>-1</sup> was prepared. After dissolving and standing overnight, it was filtrated through a PTFE filter with a pore size of 0.22&#xa0;&#xb5;g. The test temperature was 298&#xa0;K, DMF was the eluent, and the reference molecule was polystyrene.</p>
</sec>
<sec id="s2-7">
<title>Dynamic Light Scattering (DLS)</title>
<p>The particle sizes of the self-assembled polymer vesicles and Met@AuPPS were characterized by DLS on a Nanoparticle Size and Zeta Potential Analyzer ZS90 (Malvern Instruments Ltd, UK). The measuring angle was 90&#xb0; and test temperature was 298&#xa0;K.</p>
</sec>
<sec id="s2-8">
<title>Infrared thermal imaging</title>
<p>The thermal properties of PPS, J-AuPPS, and Met@J-AuPPS, as well as the thermal imaging effects of the samples <italic>in vivo</italic>, were captured by an infrared thermal imager (FOTRIC220&#xa0;s, China).</p>
</sec>
<sec id="s2-9">
<title>ELISA</title>
<p>The metformin (Met) ELISA Assay Kit (Zhenke, Shanghai) was used to determine the metformin content released after NIR irradiation of the Met@J-AuPPS solution. The sample wells were supplemented with 50&#xa0;&#xb5;L of Met@J-AuPPS solution irradiated by laser for different durations (1, 2, 3, 4, and 5&#xa0;min), followed by the addition of working solution. The plate was covered with film and incubated at 37&#xa0;&#xb0;C for 15&#xa0;min prior to measurement of OD values at a wavelength of 450&#xa0;nm using the ELX&#x2010;800 absorbance microplate reader. The concentration of metformin in the sample was calculated based on the standard curve obtained from the standard products.</p>
</sec>
<sec id="s2-10">
<title>Cytotoxicity evaluation</title>
<p>HUVECs (The cell lines present in this study were obtained from National Collection of Authenticated Cell Cultures) were used to determine the cytotoxicity of Met@J-AuPPS using the CCK-8 kit (Dojindo, Japan). Briefly, cells, at a concentration of 1 &#xd7; 10<sup>4</sup> cells/well, were cultured with Met@J-AuPPS (400&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>) in a 96-well-plate for 24, 48, and 72&#xa0;h. PBS was set as a control group. After washing with fresh PBS twice, the cells were stained with 10% CCK-8 solution for 4&#xa0;h. The relative cell density was determined by a microplate reader at a wavelength of 450&#xa0;nm.</p>
<p>To investigate cellular damage by Met@J-AuPPS under NIR irradiation, 1 &#xd7; 10<sup>4</sup> cells/well HUVECs were co-incubated with 400&#xa0;&#x3bc;g&#xa0;mL<sup>-1</sup> Met@J-AuPPS, and then NIR-irradiated (1,000&#xa0;mW&#xa0;cm<sup>-2</sup>) for 5&#xa0;min. Next, the cells were rinsed with PBS twice and re-cultured with fresh culture medium. On day 1, day 2, and day 3, the cell viability was determined by CCK-8 assay, as described above.</p>
</sec>
<sec id="s2-11">
<title>Cell scratch assay</title>
<p>For this assay, 1 &#xd7; 10<sup>6</sup> HUVECs per well were seeded in 6&#x2010;well plates. When the confluence of cells reached 80%, the 200&#xa0;&#xb5;L pipette tip was used to scrape the cells in a line to create wounds. Met, J-AuPPS, and Met@J-AuPPS were added to each well and irradiated with NIR (1,000&#xa0;mW&#xa0;cm<sup>-2</sup>) for 5&#xa0;min. Images were captured by inverted microscopy at 0 and 48&#xa0;h after wounding. The migration area was quantified using ImageJ software.</p>
</sec>
<sec id="s2-12">
<title>Transwell assay</title>
<p>For the transwell assay, 2 &#xd7; 10<sup>4</sup> HUVECs per well were seeded in the upper chamber of 24&#x2010;mm Transwell chambers (Corning &#x23;3412, United States) with 200&#xa0;&#xb5;L serum&#x2010;free DMEM medium. Met, J-AuPPS, and Met@J-AuPPS were added to each well and irradiated with NIR (1,000&#xa0;mW&#xa0;cm<sup>-2</sup>) for 5&#xa0;min. The lower chamber was filled with DMEM medium containing 10% FBS. After incubation for 24&#xa0;h, cells in the upper chamber were fixed with 4% paraformaldehyde solution and stained with 0.1% crystal violet for 20&#xa0;min. Subsequently, the chambers were air&#x2010;dried and images were captured. Migrated cells were quantified using ImageJ software.</p>
</sec>
<sec id="s2-13">
<title>Tube formation assay</title>
<p>The effect of Met@J-AuPPS on the tube-forming ability of HUVECs was investigated. The matrigel was thawed overnight at 4&#xa0;&#xb0;C, and sterile tips and angiogenesis slides (Ibidi, Germany) were precooled. The next day, the matrigel was quickly added to the angiogenesis slides and placed in a cell incubator for 60&#xa0;min at 37&#xa0;&#xb0;C. Then, 8 &#xd7; 10<sup>3</sup> HUVECs per well were seeded in angiogenesis slides. Next, Met, J-AuPPS, and Met@J-AuPPS were added to each well and irradiated with NIR (1,000&#xa0;mW&#xa0;cm<sup>-2</sup>) for 5&#xa0;min. Angiogenesis slides were observed at 4, 6, 8, 10, and 12&#xa0;h, and photographed using an optical microscope. Tubes were quantified using ImageJ software.</p>
</sec>
<sec id="s2-14">
<title>Spread plate method</title>
<p>Methicillin-resistant <italic>S. aureus</italic> (MRSA, ATCC43300) and extended-spectrum <italic>&#x3b2;-</italic>lactamase-producing <italic>E. coli</italic> (ESBL <italic>E. coli</italic>, ATCC35218) were selected as the two types of model bacteria. Single colonies were transplanted into tryptic soy broth (TSB) and grown at 37&#xa0;&#xb0;C overnight. The harvested cultures were centrifuged and adjusted to 10<sup>8</sup>&#xa0;CFU&#xa0;mL<sup>-1</sup>. After that, 10&#xa0;&#x3bc;L bacterial suspension was mixed with 1&#xa0;mL PBS (as control), J-AuPPS (400&#xa0;&#x3bc;g&#xa0;mL<sup>-1</sup>), or Met@J-AuPPS (400&#xa0;&#x3bc;g&#xa0;mL<sup>-1</sup>) in centrifuge tubes with or without 808&#xa0;nm NIR irradiation (1,000&#xa0;mW&#xa0;cm<sup>&#x2212;2</sup>) for 10&#xa0;min. Then, 10&#xa0;&#x3bc;L of serially diluted bacterial solution was spread on a sheep blood agar plate and incubated overnight at 37&#xa0;&#xb0;C. Next, the bacterial colonies were counted.</p>
</sec>
<sec id="s2-15">
<title>Crystal violet staining</title>
<p>As-prepared bacterial solution was added into a 24-well plate and cultured for 48&#xa0;h. The plate was washed with PBS, and J-AuPPS or Met@J-AuPPS were added to each well and irradiated with NIR (1,000&#xa0;mW&#xa0;cm<sup>-2</sup>) for 10&#xa0;min. After washing again, the biofilm was fixed with 4% paraformaldehyde solution for 10&#xa0;min and stained with 0.1% crystal violet for 20&#xa0;min. Then, 3% glacial acetic acid solution was used for decolorization of crystal violet in the biofilm. The OD value of each well was determined at 595&#xa0;nm wavelength.</p>
</sec>
<sec id="s2-16">
<title>Live/dead staining to assess bacterial viability</title>
<p>A sterile pure titanium disk was immersed into as-prepared bacterial solution and co-incubated for 48&#xa0;h at 37&#xa0;&#xb0;C. Then, titanium was gently rinsed with aseptic PBS twice and re-immersed into PBS (control), J-AuPPS and Met@J-AuPPS under NIR laser irradiation (1,000&#xa0;mW&#xa0;cm<sup>-2</sup>) for 10&#xa0;min. Next, the titanium disk was rinsed with PBS twice. A Bacterial Live/Dead Staining Kit was used to visualize the ratio of live cells/dead cells in the biofilm. Briefly, as-prepared titanium disks were immersed in a 1&#xa0;mL mixture of STYO9 and PI (1: 1,000 v/v in saline) in a 24-well-plate. After co-culturing for 30&#xa0;min, the live/dead cells encapsulated in biofilm were observed with CLSM.</p>
</sec>
<sec id="s2-17">
<title>SEM of biofilm</title>
<p>The as-treated titanium disks were fixed with 2.5% glutaraldehyde solution at 4&#xa0;&#xb0;C overnight, followed by sequential dehydration in a serial dilution of ethanol (30, 50, 70, 85, 90, 95% and 100%, v/v) for 10&#xa0;min, according to standard procedures. Next, titanium disks were freeze-dried for 24&#xa0;h prior to scanning electron microscopy.</p>
</sec>
<sec id="s2-18">
<title>Treatment of diabetic infected wounds <italic>in vivo</italic>
</title>
<p>All animal experimental procedures were performed in accordance with guidelines, and approved by the Ethics Committee of Shanghai Jiaotong University School of Medicine Affiliated Shanghai Sixth People&#x2019;s Hospital (No.DWLL205-0010). A diabetic infected wound model was constructed using SD rats (&#x223c;250&#xa0;g), and all rats were anesthetized by an intraperitoneal injection of pentobarbital sodium at a dose of 40&#xa0;mg/kg. A diabetic rat model was established with Streptozocin (STZ) by intraperitoneal injection. A circular wound (1&#xa0;cm) was created on the dorsal area of each rat after 2-week feeding. The wound was inoculated with MRSA bacteria (1 &#xd7; 10<sup>7</sup>&#xa0;CFU/mL), and a biofilm was formed after 2 days to construct a wound infection model in diabetic rats.</p>
<p>The rats were then randomly divided into eight groups: NIR (&#x2b;) groups: PBS, Met, J-AuPPS, and Met@J-AuPPS groups; NIR (&#x2212;) groups: PBS, Met, J-AuPPS, and Met@J-AuPPS groups. Next, 50&#xa0;&#x3bc;L of samples were added on the wound with or without NIR laser irradiation (1,000&#xa0;mW&#xa0;cm<sup>&#x2212;2</sup>) for 5&#xa0;min, and local temperature changes were recorded. The skin wounds of rats were observed and photographed on days 3, 6, 9, and 12. On day 6 and day 12, rats were euthanized for further analysis. Skin tissues as well as major organs, including heart, liver, spleen, lung, and kidney, were collected for H&#x26;E staining, Masson staining, Giemsa staining, and immunofluorescence staining.</p>
</sec>
<sec id="s2-19">
<title>Statistical analysis</title>
<p>Prism nine software (GraphPad, US) and Origin 9 (OriginLab, US) were used for data analyses. The data were presented as the mean &#xb1; SD. T-test or one-way ANOVA was used for statistical analysis. A value of P &#x3c; 0.05 was considered to indicate statistical significance, indicated as &#x2a;P &#x3c; 0.05, &#x2a;&#x2a;P &#x3c; 0.01, and &#x2a;&#x2a;&#x2a;P &#x3c; 0.001.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Preparation and Characterization of Met@J-AuPPS</title>
<p>First, ZnTHPG was synthesized according to a previous study (<xref ref-type="bibr" rid="B21">Liu et al., 2020</xref>). The <sup>1</sup>H NMR spectrum of ZnTHPG is shown in <xref ref-type="sec" rid="s13">Supplementary Figure S1</xref>. Subsequently, the assembly procedure was then started by gradually adding water to the ZnTHPG/N,N-dimethylformamide (DMF) solution of the polymer in order to begin supramolecular polymerization and hydrophilic-hydrophobic interactions between porphyrin molecules. During the synthesis of PPS, we added metformin to the polymer solution to prepare metformin-loaded PPS (Met@PPS). The proportions of metformin were 1%, 2%, and 5%, respectively.</p>
<p>Transmission electron microscopy (TEM), scanning electron microscopy (SEM), and dynamic light scattering (DLS) were used to analyze the morphology and structure of the as-prepared PPS and Met@PPS(<xref ref-type="fig" rid="F1">Figure 1A,B</xref>; <xref ref-type="sec" rid="s13">Supplementary Figure S2</xref>). As shown in <xref ref-type="fig" rid="F1">Figure 1</xref>, PPS, 1%Met@PPS, 2%Met@PPS, and 5%Met@PPS all formed smooth vesicle structures with uniform size. Some vesicles aggregated, which may have been due to the hydrophilic structure of the PPS vesicle surface. The DLS results showed that the vesicle size was similar between the four groups, indicating that the concentration of metformin had no significant effect on the uniformity and distribution of vesicle size. These results suggest that metformin does not interfere with the self-assembly of ZnTHPG. Therefore, we speculate that the properties of ZnTHPG loaded with metformin should be the same as those of hollow PPS, which provides the foundation for the synthesis and application of subsequent materials.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Preparation, characterization, photothermal and metformin release performances of Met@J&#x2010;AuPPS. <bold>(A)</bold> SEM images of PPS and Met@PPS; <bold>(B)</bold> DLS results of PPS and Met@PPS; <bold>(C)</bold> TEM images of J&#x2010;AuPPS and Met@J&#x2010;AuPPS; <bold>(D)</bold> UV&#x2013;vis absorption spectra of J&#x2010;AuPPS and Met@J&#x2010;AuPPS; <bold>(E)</bold> Infrared thermal images and <bold>(F)</bold> temperature change of PBS, J&#x2010;AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J&#x2010;AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) under an 808 nm laser (1000 mW cm<sup>&#x2212;2</sup>); <bold>(G)</bold>The heating and cooling cycles of J&#x2010;AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>, 1000 mW cm<sup>&#x2212;2</sup>); <bold>(H)</bold> Metformin release curve of Met@J&#x2010;AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) under an 808 nm laser (1000 mW cm<sup>&#x2212;2</sup>).</p>
</caption>
<graphic xlink:href="fbioe-14-1753425-g001.tif">
<alt-text content-type="machine-generated">Panel A shows SEM images of nanoparticles with different metformin loadings; Panel B presents corresponding size distribution graphs; Panel C displays TEM images of gold-coated nanoparticles; Panel D provides UV-Vis absorbance spectra; Panel E contains thermal images over time for three tube samples under irradiation; Panel F and G show temperature change graphs; Panel H tracks metformin release over time for three formulations.</alt-text>
</graphic>
</fig>
<p>The J-AuPPS and Met@J-AuPPS heterostructures were then obtained by introducing HAuCl<sub>4</sub> as an Au source into the PPS aqueous solution at 25&#xa0;&#xb0;C while being exposed to visible light. The TEM imaging validated the Janus nanostructure (<xref ref-type="fig" rid="F1">Figure 1C</xref>). We counted more than 200 nanoparticles after the photoreaction. As can be seen from the statistical results, only one Au nanoparticle grew on most of the vesicles (<xref ref-type="sec" rid="s13">Supplementary Figure S3</xref>). To verify whether the metformin was successfully loaded, we characterized materials by UV-Vis absorption spectroscopy (<xref ref-type="fig" rid="F1">Figure 1D</xref>). The absorption peak of Met@J-AuPPS was significantly higher than that of J-AuPPS at a wavelength of 400&#x2013;550&#xa0;nm, which proved that the three groups of Met@J-AuPPS were well loaded with metformin, indicating the feasibility and reliability of it.</p>
</sec>
<sec id="s3-2">
<title>Photothermal performance and metformin release of Met@J-AuPPS</title>
<p>Compared to other nanostructures, we have shown that J-AuPPS exhibits improved photothermal conversion efficiency (48.4%) and near-field enhancement effect (NFE) in the NIR spectrum (<xref ref-type="bibr" rid="B8">Chen et al., 2023b</xref>). According to the infrared thermal images, when exposed to an 808&#xa0;nm laser, Met@J-AuPPS showed a comparable temperature increase from 29.5&#xa0;&#xb0;C to 59.8&#xa0;&#xb0;C to J-AuPPS (27.4&#xa0;&#xb0;C&#x2013;63.1&#xa0;&#xb0;C) (<xref ref-type="fig" rid="F1">Figure 1E,F</xref>). Additionally, after six cycles of heating and cooling, J-AuPPS and Met@J-AuPPS retained good photothermal characteristics (<xref ref-type="fig" rid="F1">Figure 1G</xref>). These results confirm that, as expected, the loading of metformin does not adversely affect its original photothermal properties and photothermal conversion efficiency, and indicate that Met@J-AuPPS has satisfactory photothermal properties. Next, we tested the metformin release capacity of 1% Met@J-AuPPS, 2% Met@J-AuPPS, and 5% Met@J-AuPPS (<xref ref-type="fig" rid="F1">Figure 1H</xref>). Met@J-AuPPS showed higher metformin release rate within 1&#xa0;min, and almost all metformin was released within 5&#xa0;min.</p>
</sec>
<sec id="s3-3">
<title>Pro-angiogenesis ability <italic>in vitro</italic>
</title>
<p>Good biocompatibility is a prerequisite for the application of Met@J-AuPPS in diabetic wound healing. The cytotoxicity of J-AuPPS to cells was comparatively low when the feeding concentration was less than 400&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>, in our previous research (<xref ref-type="bibr" rid="B8">Chen et al., 2023b</xref>). J-AuPPS and 1%/2%/5% Met@J-AuPPS (400&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>) were respectively co-cultured with HUVECs. CCK-8 assay revealed no significant difference in cell activity between the groups after 24, 48, and 72&#xa0;h (<xref ref-type="sec" rid="s13">Supplementary Figure S4A</xref>). Moreover, NIR-activated J-AuPPS and Initially, Met@J-AuPPS caused enormous cell death, although this effect was partly lost after being cultured for 2 and 3 days (<xref ref-type="sec" rid="s13">Supplementary Figure S4B</xref>). These findings suggest that J-AuPPS and Met@J-AuPPS can cause damage to cells due to photothermal effects induced by NIR laser irradiation, but the damage is controlled and transient. More cells still maintain normal proliferative activity to eliminate this damage. These results demonstrate that Met@J-AuPPS has further utilization prospects in biological applications. Based on the above results, 5%Met@J-AuPPS(400&#xa0;&#x3bc;g&#xa0;mL<sup>&#x2212;1</sup>) was selected for follow-up studies.</p>
<p>The effect of Met@J-AuPPS on HUVECs migration was evaluated by cell scratch test (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Compared with PBS and J-AuPPS, the number of migrated HUVECs after Met@J-AuPPS (NIR-triggered) treatment was significantly increased, showing similar effects as metformin treatment. The quantitative results of cell migration showed that the cell migration ratio of Met@J-AuPPS was significantly better than that of J-AuPPS (P &#x3c; 0.01) (<xref ref-type="fig" rid="F2">Figure 2D</xref>). The effect of Met@J-AuPPS was confirmed again by transwell migration test (<xref ref-type="fig" rid="F2">Figures 2B,E</xref>). The ability of Met@J-AuPPS to induce tube formation by HUVECs was further tested, and the number of meshes and nodes was counted. As shown in <xref ref-type="fig" rid="F2">Figures 2C F,G</xref> and only a small number of tubules were formed in the PBS group. Met@J-AuPPS induced the formation of more distinct and interconnected tubule structures by HUVECs. In summary, Met@J-AuPPS has ideal biocompatibility and good ability to promote angiogenesis <italic>in vitro</italic>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Pro-angiogenesis ability of Met@J-AuPPS in vitro. <bold>(A)</bold> Cell scratch test of HUVEC after co-incubated with J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) for 48h; <bold>(B)</bold> Transwell migration test of HUVEC after co-incubated with J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) for 24h; <bold>(C)</bold> Tube forming test of HUVEC after co-incubated with J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) for 6h; <bold>(D)</bold> Quantitative analysis of migration area of HUVECs in cell scratch test (n&#x003D;3, &#x002A;&#x002A;&#x002A;&#x002A;P &#x003c; 0.0001); <bold>(E)</bold> Quantitative analysis of the number of migrating cells in Transwell migration test (n &#x003D; 3, &#x002A;&#x002A;&#x002A;P &#x003c; 0.001); Quantitative analysis of the number of meshes <bold>(F)</bold> and the number of nodes <bold>(G)</bold> formed in the tube forming test (n &#x003D; 3, &#x002A;&#x002A;&#x002A;P &#x003c; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;P &#x003c; 0.0001).</p>
</caption>
<graphic xlink:href="fbioe-14-1753425-g002.tif">
<alt-text content-type="machine-generated">Panel A presents wound healing assays at 0 and 48 hours for four treatments: PBS, Met, J-AuPPS, and Met@J-AuPPS, showing varying levels of cell migration into the wound. Panel B displays stained migrated cells with dense purple spots, indicating migration differences among the groups. Panel C shows tube formation assays with varying network complexities. Panels D through G are bar graphs quantifying migration area, migrated cell count, number of meshes, and number of nodes, respectively, with statistical significance denoted between groups.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<title>Antibacterial and anti-biofilm activity <italic>in vitro</italic>
</title>
<p>Next, J-AuPPS and Met@J-AuPPS were evaluated for their antibacterial efficacy against MRSA and ESBL <italic>E. coli</italic>. The spread-plate method was used to assess the impact of J-AuPPS and Met@J-AuPPS on bacterial viability. As shown in <xref ref-type="fig" rid="F3">Figures 3A&#x2013;C</xref>, the NIR-activated J-AuPPS group nearly entirely scavenged MRSA or ESBL <italic>E. coli</italic> (bacterial viability &#x3c;1%), indicating that PTT has a desirable antibacterial impact against microorganisms that are resistant to many drugs. Meanwhile, Met@J-AuPPS &#x2b; NIR group showed similar results for antibacterial efficiency. The results reveal that the present nanomaterials kill both gram-negative and -positive bacteria by generating high local temperature through PTT, and metformin has no adverse effect on the PTT antibacterial properties.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Antibacterial and anti-biofilm activity of Met@J-AuPPS in vitro. <bold>(A)</bold> Colony-forming units (CFUs) on sheep blood agar plates of MRSA and ESBL <italic>E. coli</italic> after treated with PBS, J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) with or without NIR laser irradiation (808 nm, 1000 mW cm<sup>&#x2212;2</sup>) for 10 min, respectively; <bold>(B, C)</bold> CFU count of MRSA <bold>(B)</bold> and ESBL <italic>E. coli</italic> <bold>(C)</bold> for the above groups. (n &#x003D; 5, &#x002A;&#x002A;&#x002A;&#x002A;P &#x003c; 0.0001); <bold>(D)</bold> Crystal violet staining of MRSA and <italic>E.coli</italic> biofilm after treated with PBS, J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) with or without NIR laser irradiation (808 nm, 1000 mW cm<sup>&#x2212;2</sup>) for 10 min, respectively; <bold>(E,F)</bold> OD595 value of MRSA <bold>(E)</bold> and <italic>E. coli</italic> <bold>(F)</bold> for the above groups (n &#x003D; 5, &#x002A;&#x002A;&#x002A;&#x002A; p &#x003c; 0.0001); <bold>(G)</bold> SEM images of MRSA/<italic>E.coli</italic>-biofilm on the surface of Ti disk in different groups; <bold>(H)</bold> CLSM images of MRSA and<italic> E.coli</italic> biofilm on Ti disk using Bacterial Live/Dead staining in each group (red: dead cells, green: live cells) after treated with PBS, J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) with or without NIR laser irradiation (808 nm, 1000 mW cm<sup>&#x2212;2</sup>) for 10 min, respectively.</p>
</caption>
<graphic xlink:href="fbioe-14-1753425-g003.tif">
<alt-text content-type="machine-generated">Panel A shows bacterial colony growth on agar plates for MRSA and E. coli under different treatments, with and without NIR irradiation, revealing marked reduction in colonies for Met@J-AuPPS with NIR. Panel D displays stained bacterial biofilms, with Met@ J-AuPPS plus NIR visibly reducing biofilm density. Panel G includes grayscale electron microscopy images highlighting disrupted bacterial surfaces following Met@J-AuPPS plus NIR treatment. Panel H presents fluorescence microscopy images indicating substantial bacterial cell death (red) only in the Met@J-AuPPS plus NIR group. Panels B-C and E-F are bar graphs quantifying CFU counts and biofilm optical density, showing significant decreases with Met@ J-AuPPS plus NIR.</alt-text>
</graphic>
</fig>
<p>Adhesion and colonization of bacteria further lead to the formation of biofilms. Antibiotic therapy and the host immune response are both highly tolerated by bacteria in biofilms (<xref ref-type="bibr" rid="B40">Yelin and Kishony, 2018</xref>). Therefore, the anti-biofilm properties of Met@J-AuPPS and J-AuPPS were assessed. Subsequently, following a 48-h biofilm-forming culture, MRSA and ESBL <italic>E. coli</italic> were exposed to NIR laser irradiation while being treated with J-AuPPS and Met@J-AuPPS. Using crystal violet staining, the biomass was examined to assess each sample&#x2019;s anti-biofilm efficacy (<xref ref-type="fig" rid="F3">Figures 3D&#x2013;F</xref>). The biofilm elimination efficiency of the J-AuPPS and Met@J-AuPPS groups with NIR irradiation was 45.8% and 56.4%, respectively, according to the normalization of staining findings. Moreover, SEM was used to visualize the morphological changes of biofilms on the titanium (Ti) surface. The NIR-activated J-AuPPS and Met@J-AuPPS groups only had sporadic bacteria, but the control group had a dense bacterial cluster (<xref ref-type="fig" rid="F3">Figure 3G</xref>). In addition, the bacterial live/dead (green/red) staining assay was used to assess the therapeutic efficacy of J-AuPPS and Met@J-AuPPS. The mature biofilms were thick and undamaged in control groups, which were stained green (<xref ref-type="fig" rid="F3">Figure 3H</xref>). The NIR-activated J-AuPPS and Met@J-AuPPS groups, on the other hand, showed greater red fluorescence and a sparser biofilm, indicating that the biofilm structure was disrupted down and that the sealed bacteria were significantly reduced. These findings showed that the anti-biofilm properties of Met@J-AuPPS and NIR-activated J-AuPPS are comparable <italic>in vitro</italic>.</p>
</sec>
<sec id="s3-5">
<title>NIR-triggered treatment in infected wound model of diabetic rats</title>
<p>Based on the results that Met@J-AuPPS demonstrated ideal <italic>in vitro</italic> biocompatibility and excellent <italic>in vitro</italic> antibacterial ability, the ability of Met@J-AuPPS to accelerate infected wound healing was evaluated by establishing a MRSA-infected full-thickness skin defect diabetic rat model. The progression is illustrated in <xref ref-type="fig" rid="F4">Figure 4A</xref>. The treatments were divided into eight groups: PBS, Met, J-AuPPS, Met@J-AuPPS, PBS &#x2b; NIR, Met &#x2b; NIR, J-AuPPS &#x2b; NIR, Met@J-AuPPS &#x2b; NIR(<xref ref-type="fig" rid="F4">Figures 4B,C</xref>). Wound photographs were taken on the 3rd, 6th, 9th, and 12th day to assess the degree of wound healing. The Met@J-AuPPS &#x2b; NIR group showed the best healing status without visible scarring (<xref ref-type="fig" rid="F4">Figure 4D</xref>). The relative wound area with time (<xref ref-type="fig" rid="F4">Figure 4E</xref>) showed that the healing rates of wounds in the Met, Met &#x2b; NIR, J-AuPPS &#x2b; NIR, and Met@J-AuPPS &#x2b; NIR groups were much faster than those in other groups. Notably, the relative wound area of the Met@J-AuPPS &#x2b; NIR group was the smallest among all the groups at day 12.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>NIR-triggered treatment in infected wound model of diabetic rats. <bold>(A)</bold> Flow chart of Met@J-AuPPS treatment of infected wounds in diabetic rats. <bold>(B)</bold> Infrared thermal images and <bold>(C)</bold> temperature change of PBS, Met (20 &#x03BC;g mL<sup>&#x2212;1</sup>), J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) and Met@J-AuPPS (400 &#x03BC;g mL<sup>&#x2212;1</sup>) under an 808 nm laser (1000 mW cm<sup>&#x2212;2</sup>) in the infected wound of diabetic rats. <bold>(D)</bold> Photos of biofilm infected wound of diabetic rats; <bold>(E)</bold> Quantitative analysis of relative wound area. (n &#x003D; 5, &#x002A;P &#x003c; 0.05, &#x002A;&#x002A;P &#x003c; 0.01, &#x002A;&#x002A;&#x002A;P &#x003c; 0.001,&#x002A;&#x002A;&#x002A;&#x002A; p &#x003c; 0.0001).</p>
</caption>
<graphic xlink:href="fbioe-14-1753425-g004.tif">
<alt-text content-type="machine-generated">Five-panel scientific figure. Panel A is a schematic timeline of a diabetic mouse wound infection and treatment study, indicating procedures from STZ injection, wound creation, MRSA infection, treatment, observation, to sacrifice. Panel B presents false-color infrared thermal images of mice over five minutes post-treatment, with rows for PBS, Metformin, J-AuPPS, and Met@J-AuPPS, showing thermal signal increases in certain groups. Panel C is a line graph of temperature versus time for four treatments, showing higher temperatures for J-AuPPS and Met@J-AuPPS, compared to PBS and Metformin. Panel D shows serial photographs of wounds from different groups and treatments over time, with noticeable wound healing differences. Panel E is a bar graph quantifying relative wound area (%) across time, treatment groups, and NIR irradiation presence, with significant differences marked.</alt-text>
</graphic>
</fig>
<p>These results were confirmed by H&#x26;E and Masson staining, which demonstrated the excellent performance of Met@J-AuPPS in accelerating diabetic wound healing (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). More skin defects and inflammatory cells were found in the PBS, J-AuPPS, Met@J-AuPPS, and PBS &#x2b; NIR groups. In comparison, more complete skin structure, fewer inflammatory cells, and more collagen fibers were found in the Met, Met &#x2b; NIR, J-AuPPS &#x2b; NIR, and Met@J-AuPPS &#x2b; NIR groups, especially in the Met@J-AuPPS &#x2b; NIR group. After the sixth day of wound healing, the bacterial residue was assessed by Giemsa staining (<xref ref-type="fig" rid="F5">Figure 5C</xref>). Numerous bacterial aggregates were seen in the -NIR, PBS &#x2b; NIR, and Met &#x2b; NIR groups, suggesting a serious infection. The antibacterial properties of J-AuPPS and Met@J-AuPPS under NIR irradiation contributed to the nearly total elimination of the bacteria in the J-AuPPS &#x2b; NIR and Met@J-AuPPS &#x2b; NIR groups.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Figure 5. Wound tissue analysis in vitro. <bold>(A)</bold> HE and <bold>(B)</bold> Masson staining of MRSA biofilm infected wound of diabetic rats; <bold>(C)</bold> Giemsa staining of MRSA biofilm infected wound of diabetic rats (The red arrows: residue bacterial aggregates); <bold>(D)</bold> Immunofluorescence staining of CD31, &#x03B1;-SMA and VEGF of wound tissue; <bold>(E)</bold> HE staining of heart, liver, spleen, lung and kidney of diabetic rats.</p>
</caption>
<graphic xlink:href="fbioe-14-1753425-g005.tif">
<alt-text content-type="machine-generated">Multipanel scientific figure displaying stained tissue sections for different treatment groups labeled PBS, Met, J-AuPPS, and Met@J-AuPPS, with and without NIR exposure. Panels A&#x2013;C show histological comparisons in tumor sections, including H&#x26;E, Masson&#x27;s trichrome, and vessel quantification. Panel D presents immunofluorescence staining for CD31, &#x3B1;-SMA, and VEGF (red), with nuclei (blue), across groups. Panel E displays H&#x26;E staining of heart, liver, spleen, lung, and kidney for toxicity assessment. Scale bars are indicated in micrometers.</alt-text>
</graphic>
</fig>
<p>We then performed immunostaining with CD31/&#x3b1;-SMA/VEGF, which were angiogenesis markers. It was observed that the relative coverage area of CD31/&#x3b1;-SMA/VEGF was higher in the wound areas of the Met@J-AuPPS &#x2b; NIR groups (<xref ref-type="fig" rid="F5">Figure 5D</xref>), which was attributed to the angiogenic ability of metformin and the non-infectious environment. In contrast, other groups showed a lower relative coverage area, indicating an impaired angiogenic state with increased inflammation. Finally, the vital organs were harvested and stained with H&#x26;E for biocompatible assessment (<xref ref-type="fig" rid="F5">Figure 5E</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In earlier work, we produced a Janus Au-porphyrin polymersome heterostructure which had higher photothermal conversion efficiency under 808&#xa0;nm NIR laser irradiation compared to non-Janus core&#x2013;particle Au&#x2013;porphyrin polymersome nanostructure. To explore its further applications, in this study, a Janus Au&#x2013;porphyrin polymersome heterostructure loaded with metformin was successfully constructed. We designed three proportions of metformin (1%/2%/5%) to determine the optimal drug loading concentration. Characterization of Met@J-AuPPS demonstrated that the loading of metformin had no adverse effect on the synthesis process and no significant change in the size and distribution of the polymers. Next, we detected photothermal performance and metformin release of Met@J-AuPPS. As expected, Met@J-AuPPS showed excellent photothermal conversion efficiency and similar rising temperature trend under 808&#xa0;nm NIR laser irradiation compared to J-AuPPS. However, there was a slight difference between the final drug release concentration and the expected drug concentration, which was presumably caused by three reasons. First, during the preparation of the material, not all of the added metformin was loaded into PPS vesicles or some PPS vesicles were not assembled completely. Second, the detection was only carried out for 5&#xa0;min by NIR light irradiation, and a few materials may not have been activated. Third, the detection sensitivity was limited, and there may have been experimental error.</p>
<p>In the process of diabetic wound repair, angiogenesis is crucial. Metformin was reported to stimulate angiogenesis (<xref ref-type="bibr" rid="B18">Liang et al., 2022</xref>; <xref ref-type="bibr" rid="B32">Ruan et al., 2023</xref>). Therfore, a coculture of Met@J-AuPPS and HUVEC cells was used to evaluate the effect of Met@J-AuPPS on the proliferation and migration of vascular cells. Results confirmed that Met@J-AuPPS can significantly promote the migration of HUVEC cells, and the migration of endothelial cells is also a necessary condition for the development of blood vessels. Further, we conducted tube formation experiments to explore the effect of Met@J-AuPPS on the angiogenesis ability of HUVEC. These results suggested that Met@J-AuPPS had good ability to promote angiogenesis <italic>in vitro</italic>.</p>
<p>In a hyperglycemic state, the wound is more susceptible to infection and become more difficult to heal. We found that the NIR-activated Met@J-AuPPS nearly entirely scavenged MRSA or ESBL <italic>E. coli</italic> (bacterial viability &#x3c;1%) on the plate. However, adhesion and colonization of bacteria further lead to the formation of biofilms <italic>in vivo</italic>, causing more difficult to eliminate bacteria. Thus, it is necessary to test the effect of Met@J-AuPPS in removing biofilms. Crystal violet staining revealed that Met@J-AuPPS had excellent biofilm elimination efficiency. In addition, we used SEM and CLSM to conduct more detailed observations of biofilms. After treatment of Met@J-AuPPS, the destruction of bacterial structure, shrinkage and distortion of bacterial cells were observed. At the same time, large-scale bacterial death led to the removal of biofilms. These findings suggest that changes in the integrity of bacterial membranes were linked to the improved antibacterial action of nanostructures. As previously noted, PTT can result in membrane protein denaturation and excessive ROS accumulation within cells, both of which work together to worsen pathogenic bacteria&#x2019;s eventual damage (<xref ref-type="bibr" rid="B31">Ran et al., 2021</xref>).</p>
<p>To explore he ability of Met@J-AuPPS to accelerate infected wound healing <italic>in vivo</italic>, we constructed MRSA-infected full-thickness skin defect diabetic rat model. The Met@J-AuPPS &#x2b; NIR group showed the best healing status, due to the synergistic therapeutic effect of Met@J-AuPPS. The healing rates of wounds in the Met, Met &#x2b; NIR, and J-AuPPS &#x2b; NIR groups were also much faster than those in other groups, which indicated that photothermal antibacteria and drug-promoting angiogenesis had a positive impact on the repair of diabetic infected wounds, respectively. In addition, the wound healing of J-AuPPS &#x2b; NIR group were faster than that in Met and Met &#x2b; NIR groups. It suggested that the efficacy of metformin could not be realized unless the infection was effectively controlled. In the process of wound repair, collagen metabolism also plays an important role. More collagen fibers were found in the Met@J-AuPPS &#x2b; NIR group and it often indicated better mechanical strength of the tissue after healing. Furthermore, the staining of CD31, &#x3b1;-SMA and VEGF was used to analyze the regeneration of blood vessels. CD31 can represent newborn blood vessels in the wound, while &#x3b1;-SMA represents mature blood vessels (<xref ref-type="bibr" rid="B25">Ma et al., 2020</xref>), and VEGF is critical to neovascularization in numerous tissues under physiological and pathological conditions (<xref ref-type="bibr" rid="B36">Vempati et al., 2014</xref>). In this study, the relative coverage area of CD31/&#x3b1;-SMA/VEGF was higher in the wound areas of the Met@J-AuPPS &#x2b; NIR groups. We speculated that it was attributed to the angiogenic ability of metformin and also the non-infectious environment. Bacterial infection suppressed expression of VEGF, while metformin promoted it. More molecular mechanisms need to be further investigated.</p>
<p>There are still many limitations in this research. First, there is a lack of in-depth research on molecular mechanisms of the antibacterial, anti-biomembrane, regulation of HUVEC, and regulation of the immune system; Second, the period of study <italic>in vivo</italic> is short. We cannot predict the long-term occurrence of complications; Third, more biosafety studies such as RNA-seq test are needed to ensure clinical translation.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In this study, a Janus Au&#x2013;porphyrin polymersome heterostructure loaded with metformin was successfully constructed, with similar photothermal properties under 808&#xa0;nm NIR laser irradiation compared with J-AuPPS and excellent photothermal antibacterial and anti-biofilm activities <italic>in vitro</italic>. Furthermore, the present heterostructure has ideal biocompatibility and good ability to promote angiogenesis <italic>in vitro</italic>, with significantly enhanced therapeutic effects observed in a diabetic rat wound model. These findings show that Met@J-AuPPS is an adaptable and upgradeable nanoplatform that can be loaded with additional medications, targeting molecules, or diagnostic tools for use in additional biomedical applications.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s13">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. The animal study was approved by Animal Welfare Ethics Committee of Shanghai Sixth People&#x2019;s Hospital. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>FY: Investigation, Writing &#x2013; review and editing, Formal Analysis, Writing &#x2013; original draft, Data curation, Methodology. LY: Formal Analysis, Writing &#x2013; review and editing, Data curation, Methodology, Investigation. HS: Data curation, Software, Resources, Methodology, Writing &#x2013; review and editing. YL: Methodology, Writing &#x2013; review and editing. YZ: Resources, Funding acquisition, Visualization, Validation, Writing &#x2013; review and editing, Supervision, Conceptualization. XY: Conceptualization, Visualization, Writing &#x2013; review and editing, Supervision, Project administration, Funding acquisition, Resources, Validation.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2026.1753425/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2026.1753425/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xc1;lvaro-Afonso</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Morales</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>L&#xf3;pez-Moral</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alou-Cervera</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Molines-Barroso</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>L&#xe1;zaro-Mart&#xed;nez</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Comparative clinical outcomes of patients with diabetic foot infection caused by methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-sensitive Staphylococcus aureus (MSSA)</article-title>. <source>International Journal Lower Extremity Wounds</source> <volume>24</volume> (<issue>2</issue>), <fpage>392</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1177/15347346221094994</pub-id>
<pub-id pub-id-type="pmid">35414276</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armstrong</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Boulton</surname>
<given-names>A. J. M.</given-names>
</name>
<name>
<surname>Bus</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Diabetic foot ulcers: a review</article-title>. <source>Jama</source> <volume>330</volume> (<issue>1</issue>), <fpage>62</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2023.10578</pub-id>
<pub-id pub-id-type="pmid">37395769</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aumiller</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Dollahite</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Pathogenesis and management of diabetic foot ulcers</article-title>. <source>JAAPA Official Journal Am. Acad. Physician Assistants.</source> <volume>28</volume> (<issue>5</issue>), <fpage>28</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1097/01.JAA.0000464276.44117.b1</pub-id>
<pub-id pub-id-type="pmid">25853673</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boomi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ganesan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Prabu Poorani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jegatheeswaran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Balakumar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gurumallesh</surname>
<given-names>P. H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Phyto-engineered gold nanoparticles (AuNPs) with potential antibacterial, antioxidant, and wound healing activities under <italic>in vitro</italic> and <italic>in vivo</italic> conditions</article-title>. <source>Int. Journal Nanomedicine</source> <volume>15</volume>, <fpage>7553</fpage>&#x2013;<lpage>7568</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S257499</pub-id>
<pub-id pub-id-type="pmid">33116487</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Martino</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Pijpers</surname>
<given-names>I. A. B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Photoactivated nanomotors <italic>via</italic> aggregation induced emission for enhanced phototherapy</article-title>. <source>Nat. Communications</source> <volume>12</volume> (<issue>1</issue>), <fpage>2077</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-22279-w</pub-id>
<pub-id pub-id-type="pmid">33824321</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms</article-title>. <source>Theranostics</source> <volume>12</volume> (<issue>6</issue>), <fpage>2722</fpage>&#x2013;<lpage>2740</lpage>. <pub-id pub-id-type="doi">10.7150/thno.71360</pub-id>
<pub-id pub-id-type="pmid">35401820</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vilorio</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Dhatariya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jeffcoate</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lobmann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McIntosh</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2023a</year>). <article-title>Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update)</article-title>. <source>Diabetes/metabolism Research Reviews</source> <volume>40</volume>, <fpage>e3644</fpage>. <pub-id pub-id-type="doi">10.1002/dmrr.3644</pub-id>
<pub-id pub-id-type="pmid">37232034</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Valdez</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023b</year>). <article-title>A janus Au-Polymersome heterostructure with near-field enhancement effect for implant-associated infection phototherapy</article-title>. <source>Adv. Materials Deerf. Beach, Fla</source> <volume>35</volume> (<issue>3</issue>), <fpage>e2207950</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202207950</pub-id>
<pub-id pub-id-type="pmid">36300600</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhury</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>Y. Q.</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Marilyn</surname>
<given-names>T. C. L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Silver nanoparticles: advanced and promising technology in diabetic wound therapy</article-title>. <source>Mater. Science &#x26; Engineering C, Mater. Biological Applications</source> <volume>112</volume>, <fpage>110925</fpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2020.110925</pub-id>
<pub-id pub-id-type="pmid">32409075</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Singhal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Bansal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Metformin: a review of potential mechanism and therapeutic utility beyond diabetes</article-title>. <source>Drug Design, Development Therapy</source> <volume>17</volume>, <fpage>1907</fpage>&#x2013;<lpage>1932</lpage>. <pub-id pub-id-type="doi">10.2147/DDDT.S409373</pub-id>
<pub-id pub-id-type="pmid">37397787</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farha</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>French</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stokes</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>E. D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Bicarbonate alters bacterial susceptibility to antibiotics by targeting the proton motive force</article-title>. <source>ACS Infectious Diseases</source> <volume>4</volume> (<issue>3</issue>), <fpage>382</fpage>&#x2013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.7b00194</pub-id>
<pub-id pub-id-type="pmid">29264917</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foretz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guigas</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Viollet</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Metformin: update on mechanisms of action and repurposing potential</article-title>. <source>Nat. Reviews Endocrinol.</source> <volume>19</volume> (<issue>8</issue>), <fpage>460</fpage>&#x2013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-023-00833-4</pub-id>
<pub-id pub-id-type="pmid">37130947</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hicks</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Selvarajah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mathioudakis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Hines</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>J. H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Burden of infected diabetic foot ulcers on hospital admissions and costs</article-title>. <source>Ann. Vascular Surgery</source> <volume>33</volume>, <fpage>149</fpage>&#x2013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.avsg.2015.11.025</pub-id>
<pub-id pub-id-type="pmid">26907372</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>She</surname>
<given-names>Z. G.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy</article-title>. <source>Nat. Biomedical Engineering</source> <volume>2</volume> (<issue>2</issue>), <fpage>95</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-017-0187-5</pub-id>
<pub-id pub-id-type="pmid">29955439</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koh</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>DiPietro</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Inflammation and wound healing: the role of the macrophage</article-title>. <source>Expert Reviews Molecular Medicine</source> <volume>13</volume>, <fpage>e23</fpage>. <pub-id pub-id-type="doi">10.1017/S1462399411001943</pub-id>
<pub-id pub-id-type="pmid">21740602</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krizsan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Volke</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weinert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Str&#xe4;ter</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Knappe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome</article-title>. <source>Angewandte Chemie Int. Ed Engl.</source> <volume>53</volume> (<issue>45</issue>), <fpage>12236</fpage>&#x2013;<lpage>12239</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201407145</pub-id>
<pub-id pub-id-type="pmid">25220491</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaMoia</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>G. I.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cellular and molecular mechanisms of metformin action</article-title>. <source>Endocr. Reviews</source> <volume>42</volume> (<issue>1</issue>), <fpage>77</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1210/endrev/bnaa023</pub-id>
<pub-id pub-id-type="pmid">32897388</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>pH/Glucose dual responsive metformin release hydrogel dressings with adhesion and self-healing <italic>via</italic> dual-dynamic bonding for athletic diabetic foot wound healing</article-title>. <source>ACS Nano</source> <volume>16</volume> (<issue>2</issue>), <fpage>3194</fpage>&#x2013;<lpage>3207</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.1c11040</pub-id>
<pub-id pub-id-type="pmid">35099927</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duelge</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Entropy-driven pattern formation of hybrid vesicular assemblies made from molecular and nanoparticle amphiphiles</article-title>. <source>J. Am. Chem. Soc.</source> <volume>136</volume> (<issue>6</issue>), <fpage>2602</fpage>&#x2013;<lpage>2610</lpage>. <pub-id pub-id-type="doi">10.1021/ja412172f</pub-id>
<pub-id pub-id-type="pmid">24447129</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Magneto-plasmonic janus vesicles for magnetic field-enhanced photoacoustic and magnetic resonance imaging of tumors</article-title>. <source>Angewandte Chemie Int. Ed Engl.</source> <volume>55</volume> (<issue>49</issue>), <fpage>15297</fpage>&#x2013;<lpage>15300</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201608338</pub-id>
<pub-id pub-id-type="pmid">27862808</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>
<italic>In situ</italic> supramolecular polymerization-enhanced self-assembly of polymer vesicles for highly efficient photothermal therapy</article-title>. <source>Nat. Communications</source> <volume>11</volume> (<issue>1</issue>), <fpage>1724</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-15427-1</pub-id>
<pub-id pub-id-type="pmid">32265490</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Recent developments on MOF-Based platforms for antibacterial therapy</article-title>. <source>RSC Medicinal Chemistry</source> <volume>12</volume> (<issue>6</issue>), <fpage>915</fpage>&#x2013;<lpage>928</lpage>. <pub-id pub-id-type="doi">10.1039/d0md00416b</pub-id>
<pub-id pub-id-type="pmid">34223159</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A novel sprayable thermosensitive hydrogel coupled with zinc modified metformin promotes the healing of skin wound</article-title>. <source>Bioact. Materials</source> <volume>20</volume>, <fpage>610</fpage>&#x2013;<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioactmat.2022.06.008</pub-id>
<pub-id pub-id-type="pmid">35846848</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management</article-title>. <source>Cardiovasc. Diabetology</source> <volume>18</volume> (<issue>1</issue>), <fpage>54</fpage>. <pub-id pub-id-type="doi">10.1186/s12933-019-0860-y</pub-id>
<pub-id pub-id-type="pmid">31029144</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Multilayer injectable hydrogel system sequentially delivers bioactive substances for each wound healing stage</article-title>. <source>ACS Applied Materials &#x26; Interfaces</source> <volume>12</volume> (<issue>26</issue>), <fpage>29787</fpage>&#x2013;<lpage>29806</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.0c06360</pub-id>
<pub-id pub-id-type="pmid">32515577</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy <italic>via</italic> the hedgehog pathway</article-title>. <source>Autophagy</source> <volume>15</volume> (<issue>5</issue>), <fpage>843</fpage>&#x2013;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2019.1569913</pub-id>
<pub-id pub-id-type="pmid">30653446</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>P</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>B</surname>
<given-names>V. B.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Advancements in polymer-based approaches in diabetic wound healing: a comprehensive review</article-title>. <source>J. Biomaterials Science Polym. Edition</source> <volume>36</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1080/09205063.2025.2492777</pub-id>
<pub-id pub-id-type="pmid">40279098</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palleria</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Leporini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maida</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Succurro</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>De Sarro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arturi</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes</article-title>. <source>Front. Neuroendocrinology</source> <volume>42</volume>, <fpage>76</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2016.07.002</pub-id>
<pub-id pub-id-type="pmid">27521218</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez-Rafael</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stefanov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Puiggal&#xed;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Del Valle</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Todorova</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Nanoparticle-driven self-assembling injectable hydrogels provide a multi-factorial approach for chronic wound treatment</article-title>. <source>Acta Biomater.</source> <volume>134</volume>, <fpage>131</fpage>&#x2013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2021.07.020</pub-id>
<pub-id pub-id-type="pmid">34271166</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Swelling-induced symmetry breaking: a versatile approach to the scalable production of colloidal particles with a janus structure</article-title>. <source>Angewandte Chemie Int. Ed Engl.</source> <volume>60</volume> (<issue>23</issue>), <fpage>12980</fpage>&#x2013;<lpage>12984</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202102164</pub-id>
<pub-id pub-id-type="pmid">33822452</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ran</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Organic photo-antimicrobials: principles, molecule design, and applications</article-title>. <source>J. Am. Chem. Soc.</source> <volume>143</volume> (<issue>43</issue>), <fpage>17891</fpage>&#x2013;<lpage>17909</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.1c08679</pub-id>
<pub-id pub-id-type="pmid">34677069</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z. R.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>H. T.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Metformin accelerates bone fracture healing by promoting type H vessel formation through inhibition of YAP1/TAZ expression</article-title>. <source>Bone Research</source> <volume>11</volume> (<issue>1</issue>), <fpage>45</fpage>. <pub-id pub-id-type="doi">10.1038/s41413-023-00279-4</pub-id>
<pub-id pub-id-type="pmid">37587136</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Senneville</surname>
<given-names>&#xc9;.</given-names>
</name>
<name>
<surname>Albalawi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>van Asten</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Abbas</surname>
<given-names>Z. G.</given-names>
</name>
<name>
<surname>Allison</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arag&#xf3;n-S&#xe1;nchez</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023)</article-title>. <source>Diabetes/metabolism Research Reviews</source> <volume>40</volume>, <fpage>e3687</fpage>. <pub-id pub-id-type="doi">10.1002/dmrr.3687</pub-id>
<pub-id pub-id-type="pmid">37779323</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suludere</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>&#xd6;z</surname>
<given-names>O. K.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Wukich</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Malone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lavery</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>MRSA infection, re-infection and clinical outcomes in diabetic foot infections</article-title>. <source>Wound Repair Regeneration Official Publication Wound Heal. Soc. Eur. Tissue Repair Soc.</source> <volume>32</volume> (<issue>4</issue>), <fpage>377</fpage>&#x2013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1111/wrr.13164</pub-id>
<pub-id pub-id-type="pmid">38419162</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Magliano</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The burden and risks of emerging complications of diabetes mellitus</article-title>. <source>Nat. Reviews Endocrinol.</source> <volume>18</volume> (<issue>9</issue>), <fpage>525</fpage>&#x2013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-022-00690-7</pub-id>
<pub-id pub-id-type="pmid">35668219</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vempati</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Popel</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Mac Gabhann</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning</article-title>. <source>Cytokine &#x26; Growth Factor Reviews</source> <volume>25</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2013.11.002</pub-id>
<pub-id pub-id-type="pmid">24332926</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vijayakumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Samal</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Mohanty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management</article-title>. <source>Int. Journal Biological Macromolecules</source> <volume>122</volume>, <fpage>137</fpage>&#x2013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.10.120</pub-id>
<pub-id pub-id-type="pmid">30342131</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Advances of hydrogel dressings in diabetic wounds</article-title>. <source>Biomaterials Science</source> <volume>9</volume> (<issue>5</issue>), <fpage>1530</fpage>&#x2013;<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1039/d0bm01747g</pub-id>
<pub-id pub-id-type="pmid">33433534</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yazdanpanah</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nasiri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adarvishi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Literature review on the management of diabetic foot ulcer</article-title>. <source>World Journal Diabetes</source> <volume>6</volume> (<issue>1</issue>), <fpage>37</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.4239/wjd.v6.i1.37</pub-id>
<pub-id pub-id-type="pmid">25685277</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yelin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kishony</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antibiotic resistance</article-title>. <source>Cell</source> <volume>172</volume> (<issue>5</issue>), <fpage>1136-.e1</fpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.018</pub-id>
<pub-id pub-id-type="pmid">29474914</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zakikhani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dowling</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fantus</surname>
<given-names>I. G.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pollak</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells</article-title>. <source>Cancer Research</source> <volume>66</volume> (<issue>21</issue>), <fpage>10269</fpage>&#x2013;<lpage>10273</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-1500</pub-id>
<pub-id pub-id-type="pmid">17062558</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Saint-Cricq</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Tailored synthesis of octopus-type janus nanoparticles for synergistic actively-targeted and chemo-photothermal therapy</article-title>. <source>Angewandte Chemie Int. Ed Engl.</source> <volume>55</volume> (<issue>6</issue>), <fpage>2118</fpage>&#x2013;<lpage>2121</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201510409</pub-id>
<pub-id pub-id-type="pmid">26732130</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Preparation of a one-dimensional nanorod/metal organic framework janus nanoplatform <italic>via</italic> side-specific growth for synergistic cancer therapy</article-title>. <source>Biomaterials Science</source> <volume>7</volume> (<issue>4</issue>), <fpage>1696</fpage>&#x2013;<lpage>1704</lpage>. <pub-id pub-id-type="doi">10.1039/c8bm01591k</pub-id>
<pub-id pub-id-type="pmid">30747179</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Glucose-responsive biomimetic nanoreactor in bacterial cellulose hydrogel for antibacterial and hemostatic therapies</article-title>. <source>Carbohydr. Polymers</source> <volume>292</volume>, <fpage>119615</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2022.119615</pub-id>
<pub-id pub-id-type="pmid">35725195</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3155696/overview">Fang Zhou</ext-link>, Qingdao University, China</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2995789/overview">Mena Krishnan</ext-link>, University of Nebraska Medical Center, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3166879/overview">Meiling Wen</ext-link>, Taiyuan University of Technology, China</p>
</fn>
</fn-group>
</back>
</article>